Skip to main content

Table 6 Treatment outcomes of with platinum vs. without platinum

From: Gemcitabine-based versusfluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study

  With Platinum Without Platinum P value
Number of patients 177 66  
RR (%) 20.6 12.7 0.169
DCR (%) 60.6 46.0 0.049
PFS (months) 4.4 (95% CI, 3.7–5.1) 3.3 (95% CI, 2.3–4.3) 0.887
OS (months) 8.1 (95% CI, 7.0–9.3) 10.6 (95% CI, 7.9–13.2) 0.257
  1. RR, response rate; DCR, disease control rate; PFS, progression free survival; CI, confidence interval; OS, overall survival